Kyla Omilusik
Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
T-cell and B-cell Immunology, Immune Cell Function and Interaction, CAR-T cell therapy research, Immunotherapy and Immune Responses, Single-cell and spatial transcriptomics
Most-Cited Works
- → Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours(2017)657 cited
- → The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments(2021)318 cited
- → Heterogenous Populations of Tissue-Resident CD8+ T Cells Are Generated in Response to Infection and Malignancy(2020)282 cited
- → Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses(2020)266 cited
- → Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection(2015)251 cited
- → Tissue-resident memory CD8+ T cells possess unique transcriptional, epigenetic and functional adaptations to different tissue environments(2022)224 cited
- → Early precursors and molecular determinants of tissue-resident memory CD8 + T lymphocytes revealed by single-cell RNA sequencing(2020)215 cited
- → Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors(2008)181 cited
- → Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes(2021)180 cited
- → A CD74-dependent MHC class I endolysosomal cross-presentation pathway(2012)151 cited